Sally Murray. Show Affiliations »
Abstract
Entities: Chemical
Mesh: See more » CanadaCyclooxygenase Inhibitors/adverse effectsCyclooxygenase Inhibitors/therapeutic useDecision MakingDrug ApprovalDrug IndustryDrug LabelingExpert TestimonyHumansLactones/adverse effectsLactones/therapeutic useLiability, LegalSulfones/adverse effectsSulfones/therapeutic use
Substances: See more » Cyclooxygenase InhibitorsLactonesSulfonesrofecoxib
Year: 2005 PMID: 16103502 PMCID: PMC1188214 DOI: 10.1503/cmaj.050901
Source DB: PubMed Journal: CMAJ ISSN: 0820-3946 Impact factor: 8.262